1-20 of 1314
treatment effectiveness
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mental Health and Treatment in Patients with Immune Thrombocytopenia (ITP); Data from the Platelet Disorder Support Association (PDSA) Patient Registry

Free
Alexandra Kruse, Caroline Kruse, Nancy Potthast, Kelsey Milligan, James B. Bussel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2362.
https://doi.org/10.1182/blood-2019-122278
Published: 2019
Journal Articles

The Oxygenscan Provides Clinically Relevant Biomarkers for Treatment Efficacy That Are Associated with Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease

Free
Minke A.E. Rab, MD, Richard van Wijk, PhD, Celeste K. Kanne, BA, Brigitte A. van Oirschot, Jennifer Bos, Camille Boisson, Maite E. Houwing, MD, Jorn J. Gerritsma, MD, Karin Fijnvandraat, MD PhD, Celine Renoux, PhD, Marije Bartels, MD PhD, Erfan Nur, MD PhD, Marjon H. Cnossen, MD PhD, Philippe Joly, PhD, Romain Fort, MD, Philippe Connes, PhD, Eduard J. van Beers, MD PhD, Vivien A. Sheehan, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2275.
https://doi.org/10.1182/blood-2019-128870
Published: 2019
Journal Articles

Is It Necessary to Combine Glucocorticoid in Newly Diagnosed ITP Infant Under 1 Year-Old with Severe Thrombocytopenia When Based on Intravenous Immunoglobulin Treatment ?

Free
Shayi Jiang, MD, Eric S. Sandler, MD, Hui Jiang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2368.
https://doi.org/10.1182/blood-2019-124827
Published: 2019
Journal Articles

Treatment of Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease Patients By an Anti-C5 Antibody

Free
Aline Floch, MD MSc, Alexandre Morel, MD, Fabian Zanchetta-Balint, Catherine Cordonnier-Jourdin, PharmD, Slimane Allali, MD, Maximilien Grall, MD, Ghislaine Ithier, MD, Benjamin Carpentier, MD, Sadaf Pakdaman, Jean-Claude Merle, MD, Radjiv Goulabchand, MD, Tackwa Khalifeh, MD, Ana Berceanu, MD, Christelle Chantalat-Auger, MD, Véronique Frémeaux-Bacchi, MD, Marc Michel, Armand Mekontso-Dessap, MD PhD, Anoosha Habibi, France Pirenne, MD PhD, Pablo Bartolucci, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2458.
https://doi.org/10.1182/blood-2019-127176
Published: 2019
Journal Articles

A Prospective Cohort of Black Patients with Mycosis Fungoides and Sézary Syndrome: Subset Analysis of the Mavoric Trial

Free
William T Johnson, DO, Saritha Kartan, MD, Neda Nikbakht, MD PhD, Pierluigi Porcu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4766.
https://doi.org/10.1182/blood-2019-126313
Published: 2019
Journal Articles

Biomarker Response to Oral Eliglustat in Adults with Gaucher Disease Type 1: Results from 4 Completed Clinical Trials

Free
Neal J Weinreb, MD, Timothy M Cox, MD, Pramod K. Mistry, MD PhD FRCP, Joel Charrow, MD, Elena Lukina, MD PhD Professor, Meredith C. Foster, ScD, M. Judith Peterschmitt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4859.
https://doi.org/10.1182/blood-2019-127337
Published: 2019
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

Free
Samia Harbi, MD, Raynier Devillier, MD PhD, Sabine Furst, MD, Luca Castagna, Angela Granata, MD, Faezeh Legrand, MD, Thomas Pagliardini, MD, Valerio Maisano, MD, Christian Chabannon, MD PhD, Jean Elcheikh, MD, Colombe Saillard, MD, Marie Anne Hospital, Evelyne D'Incan, Catalina Montes De Oca, MD, Nawel Belmecheri, MD, Catherine Faucher, Claude Lemarie, Pharm.D., Boris Calmels, Pharm.D., Djamel Mokart, Cecile Braticevic, Maud Cecile, Reda Bouabdallah, Norbert Vey, MD PhD, Didier Blaise, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4625.
https://doi.org/10.1182/blood-2019-131845
Published: 2019
Journal Articles

A Discrete Event Simulation Model to Evaluate the Impact of Treatment Sequences on Long-Term Patient Outcomes in Multiple Myeloma (MM)

Free
Jinan Liu, PhD, Daniel Moldaver, PhD, Xinmei Zhu, PhD, Allen Zhou, BASc, Eric M Maiese, PhD, Sarah Hollmann, M.Biotech
Journal: Blood
Blood (2019) 134 (Supplement_1): 4737.
https://doi.org/10.1182/blood-2019-123804
Published: 2019
Journal Articles

Notch1 mutation in B Chronic Lymphocytic Lymphocytes Induces Proliferation through Cell Cycle G1/S Phase-Specific Cyclin Overexpression

Free
Ana M Hurtado López, Tzu Hua Chen-Liang, María Zurdo, Anna Puiggros, PhD, Andrea Gómez-Llonín, B.Sc., María-Dolores García-Malo, MD, Francisco José Ortuño, Vicente Vicente Garcia, MD PhD, Blanca Espinet, PhD, Andres Jerez
Journal: Blood
Blood (2019) 134 (Supplement_1): 851.
https://doi.org/10.1182/blood-2019-127960
Published: 2019
Journal Articles

Integrative Immunogenomic Characterization of Diffuse Large B-Cell Lymphoma (DLBCL) Identifies Four Molecular Subtypes with Distinct Immune Landscapes

Free
Michael Leukam, MDMS, James Godfrey, MD, Sravya Tumuluru, Girish Venkataraman, MD MBBS, Sonali M. Smith, MD, Riyue Bao, PhD, Justin Kline, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 924.
https://doi.org/10.1182/blood-2019-131562
Published: 2019
Journal Articles

Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma (MCL)

Free
Mitchell Smith, MD PhD, Opeyemi Jegede, PhD, Samir Parekh, MD, Curtis A. Hanson, MD, Peter Martin, FRCPC, MD MS, Brian G. Till, MD, Michael Crump, MD FRCPC, John P. Leonard, MD, Jonathan W. Friedberg, MD, Brad S. Kahl, MD, Thomas E. Witzig, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 751.
https://doi.org/10.1182/blood-2019-129323
Published: 2019
Journal Articles

Breaking the Glass Ceiling of Age in Transplant in Multiple Myeloma

Free
Pashna N. Munshi, MD, Parameswaran Hari, MBBS, MD, David H. Vesole, MD PhD, Artur Jurczyszyn, MD, Jan Zaucha, MD PhD, Omar Davila, Shaji K. Kumar, MD, Nina D. Shah, MD, Muzaffar H. Qazilbash, MD, Anita D'Souza, MDMS
Journal: Blood
Blood (2019) 134 (Supplement_1): 782.
https://doi.org/10.1182/blood-2019-124804
Published: 2019
Journal Articles

No Improvement in Survival for T-PLL Patients over the Last Two Decades

Free
Matthew J Cross, MBBS, BSc, Monica Else, Ricardo Morilla, Mark Edward Ethell, MD, Michael Potter, MD, Dima El-Sharkawi, Sunil Iyengar, MBBS, FRCPath, PhD, Claire E. Dearden, MD FRCP, FRCPath
Journal: Blood
Blood (2019) 134 (Supplement_1): 1552.
https://doi.org/10.1182/blood-2019-122094
Published: 2019
Journal Articles

Somatic Mutation Profile Analyzed By Next-Generation Sequencing in Relapsed/Refractory Follicular Lymphoma Treated with Idelalisib

Free
Philippine Robert, Cédric Rossi, MD PhD, Romain Aucagne, PhD, Caroline Chapusot, Selim Ramla, MD, Robin Noel, MD, Reda Bouabdallah, Morgan Avenin, MD, Luc Xerri, MD PhD, Elise Toussaint, MD, Marie-Pierre Chenard, MD PhD, Luc Mathieu Fornecker, MD PhD, Adrien Chauchet, MD, Isabelle Bedgedjian, MD, Anne Quinquenel, MD, Saviz Nasri, Aude Marchal, MD PhD, Alain Jacques Delmer, MD PhD, Juliette Bouteloup, MD, Jean-Noel Bastie, MD PhD, Laurent Martin, MD PhD, Mary Callanan, PhD, Olivier Casasnovas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1503.
https://doi.org/10.1182/blood-2019-126459
Published: 2019
Journal Articles

Angioimmunoblastic T-Cell Lymphoma: Molecular Characterization of Clonal T and B-Cells and a Patient Derived Xenograft Model of Coexisting T and B-Cell Proliferations

Free
Xiaoxian Zhao, PhD, Bartlomiej Przychodzen, Juraj Bodo, PhD, Lisa Durkin, Daniel Lindner, MD PhD, Neetha Parameswaran, PhD, Michael Clemente, MS, Sarah L. Ondrejka, DO, Jaroslaw P. Maciejewski, MD PhD, Deepa Jagadeesh, MDMPH, Eric D. Hsi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1572.
https://doi.org/10.1182/blood-2019-129131
Published: 2019
Journal Articles

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain

Free
Sheila K Pierson, MS, Yue Ren, Johnson Khor, Eric Haljasmaa, Jasira Ziglar, Katherine Floess, Erin NaPier, Faizaan Akhter, Amy Y Liu, Damilola Gibson, Karan Kanhai, MD PhD, Rabecka Martin, PhD, Amy Chadburn, MD, Gordan Srkalovic, MD PhD, Megan S. Lim, MD PhD, Corey Casper, MD MPH, Thomas S. Uldrick, MD MS, Elaine S. Jaffe, MD, Frits van Rhee, MD PhD, Hongzhe Lee, PhD, David C Fajgenbaum, MDMBA,MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 1540.
https://doi.org/10.1182/blood-2019-131367
Published: 2019
Journal Articles

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (Ixa Dara dex) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; Results of the Interim Efficacy Analysis of the Phase II HOVON 143 Study

Free
Claudia A.M. Stege, MD, Kazem Nasserinejad, Ellen van der Spek, MD PhD, Roel J.W. Van Kampen, MD PhD, Maaike Sohne, MD, Noortje Thielen, MD PhD, Yavuz Bilgin, MD PhD, Esther G.M. De Waal, MD, Inge Ludwig, MD MSc, Maria B.L. Leijs, MD, Alain Kentos, MD, Gert Jan Timmers, MD PhD, Koen de Heer, MD, Matthijs Westerman, MD, Marie Christiane Vekemans, Nazik Durdu-Rayman, MD, Nicole C.H.P. van der Burg-de Graauw, MD, Niels W. C. J. Van De Donk, MD PhD, Pieter Sonneveld, Saskia K. Klein, MD PhD, Mark-David Levin, MD PhD, Sonja Zweegman, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 695.
https://doi.org/10.1182/blood-2019-121694
Published: 2019
Journal Articles

Integrative Analysis of Baseline Prognostic Features and Achievement of Minimal Residual Disease Negativity As Predictors of Early Relapse in Transplant-Eligible Multiple Myeloma Patients

Free
Francesca Gay, MD, Gian Maria Zaccaria, Massimo Offidani, Federico Vozella, Paolo Becco, Angelo Belotti, Andrea Capra, Monica Galli, Fortunato Morabito, Luca Bertamini, Francesco Pisani, Piero Galieni, Rita Rizzi, Alessandro Gozzetti, Norbert Pescosta, Luca De Rosa, Franco Narni, Milena Gilestro, Salvatore Palmieri, Michele Cea, Patrizia Tosi, Nicola Giuliani, Pellegrino Musto, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2019) 134 (Supplement_1): 605.
https://doi.org/10.1182/blood-2019-125588
Published: 2019
Journal Articles

LOXO-305: Targeting C481S Bruton Tyrosine Kinase in Patients with Ibrutinib-Resistant CLL

Free
Aishath S Naeem, PhD, Winnie I Nguy, Svitlana Tyekucheva, PhD, Stacey M. Fernandes, BS, Vanessa Rai, BS, Kevin Ebata, PhD, Eliana B. Gomez, PhD, Barb J. Brandhuber, PhD, Stephen M. Rothenberg, MD PhD, Jennifer R Brown, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 478.
https://doi.org/10.1182/blood-2019-124362
Published: 2019
Journal Articles

Azacitidine for Pre-Emptive Treatment of Measurable-Residual Disease in MDS/AML Patients at High Risk of Hematological Relapse: Results of the Second Cohort of the RELAZA2 Trial

Free
Uwe Platzbecker, MD, Jan Moritz Middeke, MD, Katja Sockel, MD, Regina Herbst, MD, Lars R. Fransecky, MD, Dominik Wolf, MD, Schumacher Martin, MD, Alwin Krämer, MD, Richard Noppeney, MD, Juergen Novotny, MD, Gesine Bug, Katharina Götze, Karsten Spiekermann, MD, Matthias Stelljes, MD, Christoph Groth, MD, Marion Subklewe, MD, Antje Schubert, Anke Mütherig, MD, Tilmann Bochtler, MD, Marika Mende, MD, Anne Sophie Kubasch, MD, Mathias Hänel, MD, Ulrich Dührsen, Prof, MD PhD, Johannes Schetelig, MD MSc, Christoph Röllig, MD MSC, Claudia D Baldus, Gerhard Ehninger, MD, Carsten Müller-Tidow, MD, Hubert Serve, MD, Michael Kramer, M.Sc., Martin Bornhäuser, MD, Christian Thiede, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 644.
https://doi.org/10.1182/blood-2019-129926
Published: 2019